Please assess the completion status of the following clinical trial:

Trial Title: Opium Tincture Against Chronic Diarrhea - Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* • Signed informed consent before any study specific procedures~  * Able to read and understand Danish~ * Male or female with an age of 20 years or more~ * The researcher believes that the participant understands what the study entails, are capable of following instructions, can attend when needed, and are expected to complete the study.~ * The investigator will ensure that fertile female participants have a negative pregnancy test before each treatment visit and use contraception during the entity of the study.~ * Specific underlying pathophysiology has been identified, but targeted treatment (e.g. antibiotics or bile acid sequestrants) and treatment with loperamide has failed.~OR~* No specific underlying pathophysiology has been identified and treatment with loperamide has failed.~* At least 6 months post-surgery in the gastrointestinal tract~* No sign of cancer at standard clinical follow-up~* Chronic diarrhea defined as at least 3 daily bowel movements for the last week~Exclusion Criteria:~* • Known allergy towards pharmaceutical compounds similar to Dropizol.~  * Participation in other studies within 14 days of first visit (1 year if opioids involved).~ * Expected need of medical/surgical treatment during the study~ * History of psychiatric illness (e.g. mental retardation, schizophrenia, major depression)~ * History of substance abuse (e.g. alcohol, THC, benzodiazepine, central stimulants and/or opioids)~ * Family history of substance abuse~ * Known major stenosis of the intestines~ * Known severe decreased renal function (defined as eGFR below 30)~ * Known severe decreased hepatic function (defined as Child-Pugh class B or higher)~ * Treatment with MAO- inhibitors during the entity of the study~ * Severe COPD or acute severe asthma (defined as FEV1 below 50 % or acute ongoing exacerbation)~ * Known cor pulmonale~ * Female participants that are lactating~ * Medicine known to affect gastrointestinal motility must not be initiated during the entity of the study~ * Treatment with opium tincture during the last month

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Active treatment (Type: ACTIVE_COMPARATOR): Administration of opium tincture (Dropizol)
- Placebo treatment (Type: PLACEBO_COMPARATOR): Administration of placebo (identical to opium tincture in taste and appearance)

Based on this trial design, predict the completion outcome and termination type (if applicable).